# Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee

> **NCT00120900** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1340 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** GW406381

## Key facts

- **NCT ID:** NCT00120900
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 1340 (ACTUAL)
- **Last updated:** 2017-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120900, "Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00120900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*